Form 4: Applied Therapeutics Director Teena Lerner Receives Compensatory Restricted Stock Units

Director Teena Lerner acquired 45,000 shares of Applied Therapeutics common stock in the form of restricted stock units on June 6, 2024.

Summary

• Teena Lerner, a director of Applied Therapeutics, Inc., reported a transaction involving the acquisition of the company's common stock.
• On June 6, 2024, Lerner acquired 45,000 shares of common stock in the form of compensatory restricted stock units (RSUs).
• These RSUs were granted under the company's 2019 Equity Incentive Plan.
• Each RSU represents a contingent right to receive one share of Applied Therapeutics common stock.
• The RSUs vest quarterly from June 6, 2024, until the earlier of the first anniversary of the grant date or the date of the issuer's next annual stockholder meeting, subject to continuous service.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock-based compensation, which is generally viewed neutrally to positively as it aligns management interests with shareholders. There are no indications of negative news or concerns.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and contribution to the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The grant of RSUs to a director can positively impact shareholders by aligning management's interests with theirs.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates